>> Главная


"Inositol Treatment of Alzheimer's Disease: A Double-Blind, Cross-Over Placebo Controlled Trial"

Barak, Yoram, et al, Prog. Neuro-Psychopharmacol. and Biological Psychiatry, 1996;20:729-735.

In a double-blind crossover study, inositol at 6 grams per day versus glucose for 1 month each was carried out in 11 Alzheimer's disease patients. There was an overall improvement in the Cognitive Subscale of the Cambridge Mental Disorder of the Elderly Examination (CAMDEX) with inositol but it was not significant. Language and orientation improved significantly more with inositol than the placebo. There were no serious side effects. The authors feel that higher doses of inositol should be studied in Alzheimer's disease patients for longer periods of time.



Type a keyword and click on the 'Go' button to begin full-text search throughout the site.

 Printer-friendly page

Send page to a friend Send page to a friend

Bookmark this page Bookmark this page

>> Natural Health Care

>> Studies Worldwide

>> "Business With Disease"

>> International Campaign

>> Open Letter Campaign

>> Take Action

>> Features

 © 2019 Dr. Rath Health Foundation Send page to a friend contact Printer-friendly page Help Previous document Top of the page Function not available in this page Back to Homepage